BU-NOT-SET

CONTACT US
Overcoming oncolytic virus obstacles with the help of a CDMO partnership
  • Biologics
oncolytic virus
Insight
Webinar: Beyond borders: Navigating global scale-up for viral-based therapies
  • Biologics
webinar
Webinar
Choosing the right container for your sterile drug product
  • Drug product
eBook: How a CDMO partner helps choose the right container for sterile drug products
eBook
Cell and virus banking in OV development and manufacturing
  • Biologics
Cell and virus banking
White paper
Overcoming technical transfer challenges in virotherapy manufacturing
  • Biologics
virotherapy
Insight
Flexibility in gene therapy: Adapting to the unique gene therapy demands
  • Biologics
gene therapy
eBook
Webinar: An optimised Plasmid DNA platform
  • Biologics
Plasmid DNA
Webinar
The future of oral solid dose formulations
  • Drug substance
  • Industry trends
oral solid dose
Insight
Trends and challenges to impact the OSD space in 2024 and beyond
  • Industry trends
OSD
Insight
Insight
  • Industry trends
Key trends in pharmaceutical outsourcing
Insight
  • Drug product
  • Industry trends
The latest trends and innovations in oral drug delivery
Insight
  • Corporate
Recipharm invests in African vaccine production
Insight
  • Drug product
  • Industry trends
The future of oral solid dose development and manufacturing
Report
  • Sustainability
Sustainability Report 2021
Insight
  • Corporate
Treating long-COVID with Erdosteine
Insight
  • Drug product
Three trends driving small molecule API market growth
Fact sheet
  • Drug product
Vaccine manufacturing
Insight
  • Drug product
Solving the challenges during oral solid dosage development